250k Sign Petition for Access to Enhertu
A campaign led by Breast Cancer Now has garnered support from over a quarter of a million people, urging the NHS to provide a breakthrough breast cancer drug to women who have been denied access to it.
Drug's Potential to Extend Lives
The petition calls for a reversal of the decision made by England’s National Institute for Health and Care Excellence, which denied access to Enhertu for women with incurable cancer that has spread. Despite evidence showing that the drug can extend lives by six months or more, it was deemed not cost-effective by the medical watchdog.
Urgent Appeal for a Change in Decision
Baroness Delyth Morgan, the chief of Breast Cancer Now, emphasized the urgency of the situation, stating that a swift decision is needed to prevent tragic consequences for women whose lives could be cut short without access to the drug.
Flawed Decision-Making Process
The charity and pharmaceutical companies argue that Nice's decision-making process is flawed and fails to consider the potential benefits of Enhertu for women who have limited treatment options available to them.
Public Outcry for Hope
Jo Taylor from the patient group METUPUK highlighted the overwhelming support for the campaign, with a quarter of a million signatures reflecting a strong public demand for access to the life-extending drug. Women in need deserve the hope of more time to live.
To add your support to the 'Enhertu Emergency' petition, visit the online link provided by Breast Cancer Now.
